FindTrial
Sign In

Metabolic syndrome in vitiligo

Prevalence and risk factors of metabolic syndrome in vitiligo-A cross sectional study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/031393
Enrollment
178
Registered
2021-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

GSL Medical College and General Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are diagnosed with vitiligo attending during study period will be included. Comparison group includes patients with non-vitiligo and with conditions which are not known to be associated with metabolic syndrome and should be appropriately matched for age and sex will be included.

Exclusion criteria

Exclusion criteria: Women who are pregnant and lactating. Patients who are using systemic treatment for last 3 months.

Design outcomes

Primary

MeasureTime frame
This study will give information about prevalence and risk factors of metabolic syndrome in vitiligo patients and relation of metabolic syndrome to severity,duration and progression of vitiligoTimepoint: 18months—

Secondary

MeasureTime frame
This study will help in estimation of association of vitiligo with metabolic syndromeTimepoint: 18months—

Countries

India

Contacts

Public ContactBathina Navya

GSL Medical college and General Hospital

seetharamka@gmail.com9440250197

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026